FIELD: biotechnology.
SUBSTANCE: disclosed are antibodies which bind to canine and/or feline parvovirus, nucleic acids coding them, host cells for producing said antibodies. Invention also relates to pharmaceutical compositions and methods for passive immunization of a subject against canine or feline parvovirus infection, detection, and treatment of parvovirus infection.
EFFECT: obtained antibodies have improved expression characteristics.
26 cl, 8 dwg, 21 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Therapeutic antibodies to CD47 | 2016 |
|
RU2748401C2 |
| VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
| METHOD OF PURIFICATION FOR REMOVING TYROSINE SULPHATED ANTIBODIES VARIANTS, PURIFIED COMPOSITIONS | 2017 |
|
RU2793400C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| ANTI-CD38 ANTIBODIES AND FORMULATIONS | 2020 |
|
RU2826957C2 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA, AND COMPOSITIONS THEREOF, COMBINATIONS AND METHODS OF USING | 2015 |
|
RU2720282C1 |
| MOLECULES BINDING MESOTHELIN AND CD137 | 2019 |
|
RU2815066C2 |
| ANTI-PCSK9 ANTIBODY, ITS ANTIGEN-BINDING DOMAIN AND MEDICAL APPLICATION THEREOF | 2016 |
|
RU2739208C2 |
| ANTIBODIES TO DOGS' PD-1 | 2014 |
|
RU2732604C2 |
| ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE | 2016 |
|
RU2815681C1 |
